Προωθημένο
The Present and Future of the Fabry Disease Market
Fabry disease represents a complex lysosomal storage pathology caused by GLA gene defects resulting in alpha-galactosidase A enzyme inadequacy. This metabolic dysfunction triggers toxic substrate accumulation, primarily globotriaosylceramide (Gb3), causing systematic organ deterioration across renal, cardiac, and neurological systems while profoundly impacting patient survival and...
0 Σχόλια 0 Μοιράστηκε 130 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο